Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Revenues [Abstract]    
Sales of health and beauty aid products - net $ 7,513,330 $ 11,796,951
Other income 236,922 2,698
Total Revenues 7,750,252 11,799,649
Costs and Expenses    
Costs of sales 4,306,641 5,530,303
Selling, general and administrative expenses 3,718,854 5,779,409
Advertising, cooperative and promotional expenses 1,038,900 2,025,103
Research and development 126,696 167,155
Bad debt expense (recovery) (27,143) (29,225)
Interest expense 615 24
Total Costs and Expenses 9,164,563 13,472,769
Restructuring Charges 547,047 0
Total Costs and Expenses 9,711,610 13,472,769
(Loss) Income before (Benefit from) Provision for Income Taxes (1,961,358) (1,673,120)
(Benefit from) provision for income taxes (721,793) (657,730)
Net (Loss) Income $ (1,239,565) $ (1,015,390)
(Loss) Earnings per Share:    
Basic (usd per share) $ (0.18) $ (0.14)
Diluted (usd per share) $ (0.18) $ (0.14)
Weighted Average Common Shares Outstanding:    
Basic (shares) 7,006,684 7,054,442
Diluted (shares) 7,006,684 7,054,442